CorMedix
CRMD· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock +43.6% in FY2025
Joseph Todisco is the CEO of CorMedix and was paid $6.1M in FY2025 (Dec), up 159%.
Pay$100 in the stock at the end of FY21 → $287
Executives3
See all- 1Joseph TodiscoChief Executive OfficerFY2025
- 2Beth Zelnick KaufmanExecutive Vice President, Chief Legal/Compliance Officer & Corp. SecretaryFY2025
- 3Elizabeth HurlburtExecutive Vice President, Chief Operating OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allCorMedix paid its 3 named executives $13.6M in total in FY2025 (Dec). CEO Joseph Todisco was paid $6.1M of that.
| Name | |||
|---|---|---|---|
| Joseph TodiscoChief Executive Officer | Not disclosed | ||
| Beth Zelnick KaufmanExecutive Vice President, Chief Legal/Compliance Officer & Corp. Secretary | Not disclosed | ||
| Elizabeth HurlburtExecutive Vice President, Chief Operating Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for CorMedix. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board5
See all- Janet DillioneDirector · 10 yr on the boardIndependentCompensation (Chair), Nominating and Governance—Paid as an executive
- Steven LefkowitzDirector · 8 yr on the boardIndependentAudit (Chair), Strategy—Paid as an executive
- Alan W. DuntonDirector · 6 yr on the boardIndependentAudit, Compensation—Paid as an executive
- Gregory DuncanDirector · 5 yr on the boardIndependentAudit, Compensation—Paid as an executive
- Robert StewartDirector · 2 yr on the boardIndependentNominating and Governance, Strategy—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 29, 2026 | FY2025 |
| Annual report | 10-K | Mar 5, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 28, 2025 | FY2024 |
| Annual report | 10-K | Mar 25, 2025 | FY2024 |
| Proxy statement | DEF 14A | Oct 8, 2024 | FY2023 |
| Annual report | 10-K | Mar 12, 2024 | FY2023 |
